{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:07:13Z","timestamp":1788307633797,"version":"build-2803163510"},"reference-count":134,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023233","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018952","name":"Birmingham Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203326"],"award-info":[{"award-number":["NIHR203326"]}],"id":[{"id":"10.13039\/501100018952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"European Commission Horizon 2022 Program","doi-asserted-by":"publisher","award":["101095407"],"award-info":[{"award-number":["101095407"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically evaluate the impact of adrenal tumour diagnosis and targeted interventions on health-related quality of life (HRQoL) and neuropsychiatric outcomes across tumour subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search of MEDLINE, Embase, Cochrane Library, and CINAHL (January 1990-March 2026) identified studies reporting HRQoL and neuropsychiatric outcomes in adults with adrenal tumours, including non-functioning adrenal tumours (NFAT), mild autonomous cortisol secretion (MACS), adrenal Cushing's syndrome (CS), primary aldosteronism (PA), phaeochromocytoma\/paraganglioma (PPGL), and adrenocortical carcinoma (ACC). Study quality was assessed using CONSORT-PRO and Newcastle-Ottawa criteria. Due to methodological heterogeneity, findings were synthesized narratively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 117 studies involving 35 361 patients were included. CONSORT-PRO quality was good but heterogeneous, whereas observational study quality was mostly moderate or low. Across tumour subtypes, adrenal tumours were consistently associated with impaired HRQoL and neuropsychiatric outcomes. A gradient of burden was evident, with mild impairment in NFAT, intermediate impairment in MACS and PA, and the most pronounced and persistent deficits in adrenal CS, PPGL, and ACC. Targeted interventions were often associated with improved patient-reported outcomes, though the magnitude and consistency of benefit varied across tumour subtypes and study design. Recovery was frequently incomplete. Most studies relied on generic HRQoL instruments, and no disease-specific neuropsychiatric tools were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adrenal tumours are associated with substantial and often persistent impairment in patient well-being across tumour subtypes. Although treatment generally improves outcomes, residual symptoms are common, underscoring the need for long-term, patient-centred care and for the development of adrenal tumour-specific patient-reported outcome measures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag072","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:14:19Z","timestamp":1776510859000},"page":"S41-S55","source":"Crossref","is-referenced-by-count":1,"title":["Impact of diagnosis and targeted interventions on the quality of life and neuropsychiatric outcomes of patients with adrenal tumours: a systematic review"],"prefix":"10.1093","volume":"194","author":[{"given":"Barbara","family":"Ruggiero","sequence":"first","affiliation":[{"name":"Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham , Birmingham B15 2TT ,","place":["United Kingdom"]},{"name":"Faculty of Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore , Rome 00168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham , Birmingham B15 2TT ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Swan","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham , Birmingham B15 2TT ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-866X","authenticated-orcid":false,"given":"Onnicha","family":"Suntornlohanakul","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham , Birmingham B15 2TT ,","place":["United Kingdom"]},{"name":"Endocrinology and Metabolism Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University , Songkhla 90110 ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham , Birmingham B15 2TT ,","place":["United Kingdom"]},{"name":"Department of Endocrinology, Taihe Hospital, Hubei University of Medicine , Shiyan 442000 ,","place":["P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5020-2071","authenticated-orcid":false,"given":"Cristina L","family":"Ronchi","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham , Birmingham B15 2TT ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2735-6053","authenticated-orcid":false,"given":"Yasir S","family":"Elhassan","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham , Birmingham B15 2TT ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derick","family":"Yates","sequence":"additional","affiliation":[{"name":"Library and Knowledge Service, Birmingham Women's and Children's NHS Foundation Trust , Birmingham B15 2TG ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4821-0336","authenticated-orcid":false,"given":"Alessandro","family":"Prete","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham , Birmingham B15 2TT ,","place":["United Kingdom"]},{"name":"NIHR Birmingham Biomedical Research Centre, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust , Birmingham B15 2TH ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"1","key":"2026050515215714700_lvag072-B1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026050515215714700_lvag072-B2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S2213-8587(24)00378-4","article-title":"Adrenocortical carcinoma: a practical guide for clinicians","volume":"13","author":"Fassnacht","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2026050515215714700_lvag072-B3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1210\/clinem\/dgac603","article-title":"Impaired cognitive function in patients with autonomous cortisol secretion in adrenal incidentalomas","volume":"108","author":"Liu","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026050515215714700_lvag072-B4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cen.13719","article-title":"Quality of life in patients with adrenal disease: a systematic review","volume":"89","author":"Ho","year":"2018","journal-title":"Clin Endocrinol"},{"issue":"12","key":"2026050515215714700_lvag072-B5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1055\/s-0043-121706","article-title":"Health-related quality of life and mental health in primary aldosteronism: a systematic review","volume":"49","author":"Velema","year":"2017","journal-title":"Horm Metab Res"},{"issue":"11","key":"2026050515215714700_lvag072-B6","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1210\/jc.2019-01054","article-title":"Improvement but No normalization of quality of life and cognitive functioning after treatment of Cushing syndrome","volume":"104","author":"Broersen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026050515215714700_lvag072-B7","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/ejendo\/lvaf011","article-title":"Do adrenal incidentalomas have an impact on mental health? A comprehensive review","volume":"192","author":"Kastelan","year":"2025","journal-title":"Eur J Endocrinol."},{"issue":"8","key":"2026050515215714700_lvag072-B8","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"issue":"5-6","key":"2026050515215714700_lvag072-B9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000182736","article-title":"Course of depression in Cushing's syndrome: response to treatment and comparison with Graves\u2019 disease","volume":"39","author":"Sonino","year":"1993","journal-title":"Horm Res"},{"issue":"1","key":"2026050515215714700_lvag072-B10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1210\/jcem.86.1.7093","article-title":"Incidence and late prognosis of Cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026050515215714700_lvag072-B11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF03347198","article-title":"Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients","volume":"28","author":"Iacobone","year":"2005","journal-title":"J Endocrinol Invest"},{"issue":"110","key":"2026050515215714700_lvag072-B12","first-page":"166","article-title":"Depression and anxiety in patients with adrenal tumor incidentally found on abdominal imaging performed for other indications","volume":"19","author":"Owecki","year":"2005","journal-title":"Pol Merkur Lekarski"},{"issue":"5","key":"2026050515215714700_lvag072-B13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1530\/EJE-07-0762","article-title":"Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire","volume":"158","author":"Webb","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026050515215714700_lvag072-B14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/BF03346473","article-title":"Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing's syndrome","volume":"32","author":"Tauchmanova","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026050515215714700_lvag072-B15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12020-011-9456-3","article-title":"Health-related quality of life and fatigue in patients with adrenal incidentaloma","volume":"40","author":"Kastelan","year":"2011","journal-title":"Endocrine"},{"issue":"3","key":"2026050515215714700_lvag072-B16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026050515215714700_lvag072-B17","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.surg.2012.08.054","article-title":"Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome","volume":"152","author":"Iacobone","year":"2012","journal-title":"Surgery"},{"issue":"1","key":"2026050515215714700_lvag072-B18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12020-012-9856-z","article-title":"Patient-reported impacts of a conservative management programme for the clinically inapparent adrenal mass","volume":"44","author":"Muth","year":"2013","journal-title":"Endocrine"},{"issue":"9","key":"2026050515215714700_lvag072-B19","doi-asserted-by":"publisher","first-page":"E1640","DOI":"10.1210\/jc.2012-1945","article-title":"Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission","volume":"97","author":"Ragnarsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026050515215714700_lvag072-B20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1530\/EJE-12-0325","article-title":"Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice","volume":"167","author":"Santos","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026050515215714700_lvag072-B21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1530\/EJE-12-0308","article-title":"Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?","volume":"167","author":"Wagenmakers","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"S3","key":"2026050515215714700_lvag072-B22","doi-asserted-by":"publisher","first-page":"S699","DOI":"10.1245\/s10434-015-4605-1","article-title":"Long-term outcome of bilateral laparoscopic adrenalectomy measured by disease-specific questionnaire in a unique group of patients with Cushing's syndrome","volume":"22","author":"Neychev","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2026050515215714700_lvag072-B23","doi-asserted-by":"publisher","first-page":"173653","DOI":"10.1155\/2015\/173653","article-title":"Mental fatigue and executive dysfunction in patients with Cushing's syndrome in remission","volume":"2015","author":"Papakokkinou","year":"2015","journal-title":"Behav Neurol"},{"issue":"1","key":"2026050515215714700_lvag072-B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-17-0048","article-title":"Health-related quality of life of patients with hypothalamic-pituitary-adrenal axis dysregulations: a cohort study","volume":"177","author":"De Bucy","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2026050515215714700_lvag072-B25","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1530\/EC-18-0400","article-title":"Preoperative treatment with metyrapone in patients with Cushing's syndrome due to adrenal adenoma: a pilot prospective study","volume":"7","author":"Puglisi","year":"2018","journal-title":"Endocr Connect"},{"issue":"1","key":"2026050515215714700_lvag072-B26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12020-019-01839-7","article-title":"Correction to: factors predicting long-term comorbidities in patients with Cushing's syndrome in remission","volume":"64","author":"Schernthaner-Reiter","year":"2019","journal-title":"Endocrine"},{"issue":"6","key":"2026050515215714700_lvag072-B27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/cen.13600","article-title":"Worse health-related quality of life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN","volume":"88","author":"Valassi","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2026050515215714700_lvag072-B28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4158\/EP-2019-0047","article-title":"Mifepristone treatment for mild autonomous cortisol secretion due to adrenal adenomas: a pilot study","volume":"25","author":"Belokovskaya","year":"2019","journal-title":"Endocr Pract"},{"issue":"S1","key":"2026050515215714700_lvag072-B29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12893-018-0432-1","article-title":"Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism","volume":"18","author":"Citton","year":"2019","journal-title":"BMC Surg"},{"issue":"8","key":"2026050515215714700_lvag072-B30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3760\/cma.j.issn.0376-2491.2019.08.006","article-title":"Differences of brain functional alterations between subtypes of Cushing's syndrome patients","volume":"99","author":"Liu","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"4","key":"2026050515215714700_lvag072-B31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.4183\/aeb.2019.482","article-title":"Are there reliable predictors for the impaired quality of life in patients with Cushing's syndrome?","volume":"15","author":"Nankova","year":"2019","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"7","key":"2026050515215714700_lvag072-B32","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1210\/jc.2018-02204","article-title":"Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy","volume":"104","author":"Osswald","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026050515215714700_lvag072-B33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00423-019-01844-4","article-title":"Health-related quality of life in patients undergoing adrenalectomy: report from a Swedish national audit","volume":"404","author":"Thompson","year":"2019","journal-title":"Langenbecks Arch Surg"},{"issue":"9-10","key":"2026050515215714700_lvag072-B34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1159\/000508765","article-title":"Impact of adrenalectomy on cortisol-producing adenoma: longitudinal evaluation of health-related quality of life following laparoscopic adrenalectomy","volume":"104","author":"Inoue","year":"2020","journal-title":"Urol Int"},{"issue":"9","key":"2026050515215714700_lvag072-B35","doi-asserted-by":"publisher","first-page":"e3307","DOI":"10.1210\/clinem\/dgaa410","article-title":"Frailty in patients with mild autonomous cortisol secretion is higher than in patients with nonfunctioning adrenal tumors","volume":"105","author":"Singh","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026050515215714700_lvag072-B36","doi-asserted-by":"publisher","first-page":"bvab109","DOI":"10.1210\/jendso\/bvab109","article-title":"Patient and provider perspectives on postsurgical recovery of Cushing syndrome","volume":"5","author":"Acree","year":"2021","journal-title":"J Endocr Soc"},{"issue":"3","key":"2026050515215714700_lvag072-B37","doi-asserted-by":"publisher","first-page":"e1362","DOI":"10.1210\/clinem\/dgaa752","article-title":"Epidemiology and comorbidity of adrenal Cushing syndrome: a nationwide cohort study","volume":"106","author":"Ahn","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026050515215714700_lvag072-B38","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1210\/clinem\/dgaa695","article-title":"Mental health in patients with adrenal incidentalomas: is there a relation with different degrees of cortisol secretion?","volume":"106","author":"Morelli","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026050515215714700_lvag072-B39","doi-asserted-by":"publisher","first-page":"e3865","DOI":"10.1210\/clinem\/dgab450","article-title":"An open-label phase I\/IIa clinical trial of 11beta-HSD1 inhibitor for Cushing's syndrome and autonomous cortisol secretion","volume":"106","author":"Oda","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026050515215714700_lvag072-B40","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s40618-021-01509-4","article-title":"Depression: another cortisol-related comorbidity in patients with adrenal incidentalomas and (possible) autonomous cortisol secretion","volume":"44","author":"Sojat","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"2026050515215714700_lvag072-B41","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.47750\/pnr.2022.13.S06.308","article-title":"Assessment of quality of life in patients with Cushing's syndrome","volume":"13","author":"Erkinovna","year":"2022","journal-title":"J Pharm Negat Result"},{"issue":"8","key":"2026050515215714700_lvag072-B42","doi-asserted-by":"publisher","first-page":"e13114","DOI":"10.1111\/jne.13114","article-title":"Clinical presentation and etiology of Cushing's syndrome: data from ERCUSYN","volume":"34","author":"Valassi","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"2026050515215714700_lvag072-B43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/ejendo\/lvad113","article-title":"High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment","volume":"189","author":"Dogra","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026050515215714700_lvag072-B44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/ejendo\/lvad135","article-title":"Risk of dementia and psychiatric or sleep disorders after diagnosis of adrenal adenomas: a population-based cohort study","volume":"189","author":"Li","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2026050515215714700_lvag072-B45","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/ejendo\/lvad069","article-title":"Determinants of muscle function and health-related quality of life in patients with endogenous hypercortisolism: a cross-sectional study","volume":"188","author":"Li","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026050515215714700_lvag072-B46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12020-022-03214-5","article-title":"Patient reported outcomes and treatment satisfaction in patients with Cushing syndrome","volume":"79","author":"Rakovec","year":"2023","journal-title":"Endocrine"},{"issue":"6","key":"2026050515215714700_lvag072-B47","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00234-023-03156-3","article-title":"Altered thalamic volume in patients with mild autonomous cortisol secretion: a structural brain MRI study","volume":"65","author":"Sulu","year":"2023","journal-title":"Neuroradiology"},{"issue":"1","key":"2026050515215714700_lvag072-B48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/ejendo\/lvae070","article-title":"Cognitive functions and the brain-derived neurotrophic factor in patients with mild autonomous cortisol secretion","volume":"191","author":"Barlas","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2026050515215714700_lvag072-B49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ejendo\/lvae127","article-title":"Frequency of clinical signs in patients with Cushing's syndrome and mild autonomous cortisol secretion: overlap is common","volume":"191","author":"Braun","year":"2024","journal-title":"Eur J Endocrinol."},{"issue":"12","key":"2026050515215714700_lvag072-B50","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.2337\/dc25-1055","article-title":"Inadequately controlled type 2 diabetes and hypercortisolism: improved glycemia with mifepristone treatment","volume":"48","author":"DeFronzo","year":"2025","journal-title":"Diabetes Care"},{"issue":"8","key":"2026050515215714700_lvag072-B51","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.eprac.2024.05.002","article-title":"Relationship between dexamethasone suppression test cortisol level &gt;0.9 \u03bcg\/dL and depression and quality of life in adrenal incidentalomas: a single center observational case-control study","volume":"30","author":"G\u00fcne\u015f","year":"2024","journal-title":"Endocr Pract"},{"key":"2026050515215714700_lvag072-B52","doi-asserted-by":"publisher","first-page":"1373101","DOI":"10.3389\/fendo.2024.1373101","article-title":"Comparable cognitive impairment was detected in MACS and CS and alleviated after remission of hypercortisolism in MACS","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026050515215714700_lvag072-B53","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s12020-024-03935-9","article-title":"Diagnostic dilemma in Cushing's syndrome: discrepancy between patient-reported and physician-assessed manifestations","volume":"86","author":"Motomura","year":"2024","journal-title":"Endocrine"},{"issue":"2","key":"2026050515215714700_lvag072-B54","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/ejendo\/lvae097","article-title":"Prevalence and outcome of secondary hypogonadism in male patients with Cushing's syndrome and mild autonomous cortisol secretion","volume":"191","author":"Nowak","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026050515215714700_lvag072-B55","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/ejendo\/lvae157","article-title":"Cognition in patients with mild autonomous cortisol secretion at baseline and post-adrenalectomy","volume":"191","author":"Saini","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026050515215714700_lvag072-B56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/iju.iju_443_24","article-title":"Surgical and functional outcomes of bilateral synchronous adrenalectomy for functional tumors: a cohort study","volume":"41","author":"Agarwal","year":"2025","journal-title":"Indian J Urol"},{"key":"2026050515215714700_lvag072-B57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/cen.70048","article-title":"Bone health in patients with adrenal adenomas and hypercortisolism: a multicenter cross-sectional study","volume":"104","author":"Dogra","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026050515215714700_lvag072-B58","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.1210\/clinem\/dgaf525","article-title":"Psychiatric and sleep disorders in patients with non-functional adrenal tumors","volume":"111","author":"Mirzaei","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":":","key":"2026050515215714700_lvag072-B59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.eprac.2025.09.009","article-title":"Expanding the clinical profile of mild autonomous cortisol secretion: new diagnostic markers and emerging complications","volume":"32","author":"Prinzi","year":"2025","journal-title":"Endocr Pract"},{"issue":"4","key":"2026050515215714700_lvag072-B60","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1210\/clinem\/dgaf553","article-title":"Sleep disturbances in patients with Cushing syndrome and mild autonomous cortisol secretion: a cross-sectional study","volume":"111","author":"Sharma Sharma","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026050515215714700_lvag072-B61","doi-asserted-by":"publisher","first-page":"e250361","DOI":"10.1530\/EC-25-0361","article-title":"Randomized trial studying metabolic outcomes and quality of life after adrenalectomy versus conservative management for mild autonomous cortisol secretion","volume":"14","author":"Ueland","year":"2025","journal-title":"Endocr Connect"},{"issue":"5","key":"2026050515215714700_lvag072-B62","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000093956","article-title":"Psychological aspects of primary aldosteronism","volume":"75","author":"Sonino","year":"2006","journal-title":"Psychother Psychosom"},{"issue":"1324","key":"2026050515215714700_lvag072-B63","first-page":"50","article-title":"Surgical outcomes following laparoscopic adrenalectomy for treatment of Conn's syndrome (primary hyperaldosteronism) between 1999 and 2006","volume":"123","author":"Herd","year":"2010","journal-title":"N Z Med J"},{"issue":"3","key":"2026050515215714700_lvag072-B64","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026050515215714700_lvag072-B65","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1210\/jc.2011-0138","article-title":"Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and\/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026050515215714700_lvag072-B66","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J Hypertens"},{"issue":"6","key":"2026050515215714700_lvag072-B67","doi-asserted-by":"publisher","first-page":"E878","DOI":"10.1210\/jc.2010-2723","article-title":"Psychological assessment of primary aldosteronism: a controlled study","volume":"96","author":"Sonino","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026050515215714700_lvag072-B68","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.jpsychires.2012.08.025","article-title":"Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone","volume":"46","author":"Kunzel","year":"2012","journal-title":"J Psychiatr Res"},{"issue":"1","key":"2026050515215714700_lvag072-B69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3109\/15622975.2012.665480","article-title":"Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: a cross-sectional study","volume":"15","author":"Apostolopoulou","year":"2014","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"2026050515215714700_lvag072-B70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF03401320","article-title":"Sleep quality in patients with primary aldosteronism","volume":"13","author":"Hanusch","year":"2014","journal-title":"Hormones (Athens)"},{"issue":"9","key":"2026050515215714700_lvag072-B71","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2026050515215714700_lvag072-B72","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/08941939.2017.1323055","article-title":"Laparoscopic adrenalectomy for Conn's syndrome is beneficial to patients and is cost effective in England","volume":"31","author":"Christakis","year":"2018","journal-title":"J Invest Surg"},{"issue":"1","key":"2026050515215714700_lvag072-B73","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment","volume":"103","author":"Velema","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026050515215714700_lvag072-B74","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1055\/a-0628-6847","article-title":"Psychological symptoms and well-being after treatment for primary aldosteronism","volume":"50","author":"Velema","year":"2018","journal-title":"Horm Metab Res"},{"issue":"4","key":"2026050515215714700_lvag072-B75","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1530\/EC-19-0043","article-title":"Effects of chronically high levels of aldosterone on different cognitive dimensions: an investigation in patients with primary aldosteronism","volume":"8","author":"Engler","year":"2019","journal-title":"Endocr Connect"},{"key":"2026050515215714700_lvag072-B76","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jpsychires.2019.02.020","article-title":"Sleep-EEG in patients with primary aldosteronism in comparison to healthy controls and patients with depression","volume":"112","author":"Engler","year":"2019","journal-title":"J Psychiatr Res"},{"issue":"7","key":"2026050515215714700_lvag072-B77","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/iju.14016","article-title":"Changes in quality of life after laparoscopic adrenalectomy for patients with primary aldosteronism: prospective 2-year longitudinal cohort study in a Japanese tertiary center","volume":"26","author":"Ishidoya","year":"2019","journal-title":"Int J Urol"},{"issue":"4","key":"2026050515215714700_lvag072-B78","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/EC-19-0026","article-title":"A disease-specific quality of life questionnaire for primary aldosteronism","volume":"8","author":"Velema","year":"2019","journal-title":"Endocr Connect"},{"issue":"3","key":"2026050515215714700_lvag072-B79","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13419","article-title":"Quality of life in primary aldosteronism: a prospective observational study","volume":"51","author":"Buffolo","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"2026050515215714700_lvag072-B80","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpsychires.2020.07.006","article-title":"The potential pathophysiological role of aldosterone and the mineralocorticoid receptor in anxiety and depression. Lessons from primary aldosteronism","volume":"130","author":"Murck","year":"2020","journal-title":"J Psychiatr Res"},{"key":"2026050515215714700_lvag072-B81","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jpsychires.2021.02.064","article-title":"Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism\u2014implications for depression and anxiety","volume":"137","author":"Murck","year":"2021","journal-title":"J Psychiatr Res"},{"issue":"8","key":"2026050515215714700_lvag072-B82","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1530\/EC-21-0125","article-title":"Improvement in quality of life and psychological symptoms after treatment for primary aldosteronism: Asian cohort study","volume":"10","author":"Tan","year":"2021","journal-title":"Endocr Connect"},{"issue":"4","key":"2026050515215714700_lvag072-B83","doi-asserted-by":"publisher","first-page":"bvab020","DOI":"10.1210\/jendso\/bvab020","article-title":"Quality of life of primary aldosteronism patients by mineralocorticoid receptor antagonists","volume":"5","author":"Yoshida","year":"2021","journal-title":"J Endocr Soc"},{"key":"2026050515215714700_lvag072-B84","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jpsychires.2022.09.008","article-title":"Differential central regulatory mineralocorticoidreceptor systems for anxiety and depression\u2014could KCNJ5 be an interesting target for further investigations in major depression?","volume":"156","author":"Adolf","year":"2022","journal-title":"J Psychiatr Res"},{"issue":"11","key":"2026050515215714700_lvag072-B85","doi-asserted-by":"publisher","first-page":"e0277902","DOI":"10.1371\/journal.pone.0277902","article-title":"Illness perspectives in patients with primary aldosteronism","volume":"17","author":"Ragnarsson","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"2026050515215714700_lvag072-B86","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13195-023-01274-x","article-title":"Risk of dementia in primary aldosteronism compared with essential hypertension: a nationwide cohort study","volume":"15","author":"Hong","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"2026050515215714700_lvag072-B87","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000518165","article-title":"Laparoscopic adrenalectomy is beneficial for the health-related quality of life of older patients with primary aldosteronism","volume":"107","author":"Kawasaki","year":"2023","journal-title":"Urol Int"},{"issue":"1","key":"2026050515215714700_lvag072-B88","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/joim.13618","article-title":"Moderate dietary salt restriction improves blood pressure and mental well-being in patients with primary aldosteronism: the salt CONNtrol trial","volume":"294","author":"Schneider","year":"2023","journal-title":"J Intern Med"},{"key":"2026050515215714700_lvag072-B89","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jpsychires.2024.01.042","article-title":"Sleep disturbances in primary aldosteronism are associated to depressive symptoms\u2014could specific mineralocorticoidreceptors be a common pathway?","volume":"172","author":"Adolf","year":"2024","journal-title":"J Psychiatr Res"},{"issue":"2","key":"2026050515215714700_lvag072-B90","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/HYPERTENSIONAHA.123.21965","article-title":"Diagnostic delay and disease burden in primary aldosteronism: an international patient survey","volume":"81","author":"Ananda","year":"2024","journal-title":"Hypertension"},{"issue":"11","key":"2026050515215714700_lvag072-B91","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.3390\/biomedicines12112479","article-title":"Exploring the Spectrum of comorbidities associated with primary aldosteronism: insights from a large real-world case-control study","volume":"12","author":"Krieg","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"2026050515215714700_lvag072-B92","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41440-023-01412-w","article-title":"Effects of esaxerenone on blood pressure, urinary albumin excretion, serum levels of NT-proBNP, and quality of life in patients with primary aldosteronism","volume":"47","author":"Yoshida","year":"2024","journal-title":"Hypertens Res"},{"issue":"1","key":"2026050515215714700_lvag072-B93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.eprac.2023.10.003","article-title":"A prospective observational study of factors affecting the change in quality of life in patients with primary aldosteronism after treatment","volume":"30","author":"Yu","year":"2024","journal-title":"Endocr Pract"},{"issue":"13","key":"2026050515215714700_lvag072-B94","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.3390\/jcm14134618","article-title":"Primary aldosteronism and cognitive dysfunction: a case-control study","volume":"14","author":"Herceg","year":"2025","journal-title":"J Clin Med"},{"issue":"8","key":"2026050515215714700_lvag072-B95","doi-asserted-by":"publisher","DOI":"10.1111\/jch.70115","article-title":"Efficacy, quality of life, and cost-effectiveness of superselective adrenal arterial embolization in idiopathic hyperaldosteronism: a comparative study","volume":"27","author":"Khan","year":"2025","journal-title":"J Clin Hypertens"},{"key":"2026050515215714700_lvag072-B96","doi-asserted-by":"publisher","first-page":"1558837","DOI":"10.3389\/fendo.2025.1558837","article-title":"Short-term longitudinal clinical, biochemical, and quality of life outcomes of medical or surgical therapy in unilateral primary aldosteronism","volume":"16","author":"Yoshida","year":"2025","journal-title":"Front Endocrinol"},{"issue":"2","key":"2026050515215714700_lvag072-B97","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00006842-199003000-00001","article-title":"Peripheral catecholamine levels and the symptoms of anxiety: studies in patients with and without pheochromocytoma","volume":"52","author":"Starkman","year":"1990","journal-title":"Psychosom Med"},{"issue":"6","key":"2026050515215714700_lvag072-B98","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1530\/eje.0.1410619","article-title":"Pheochromocytoma in Italy: a multicentric retrospective study","volume":"141","author":"Mannelli","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"1-3","key":"2026050515215714700_lvag072-B99","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12020-008-9108-4","article-title":"Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma","volume":"34","author":"Lai","year":"2008","journal-title":"Endocrine"},{"issue":"1","key":"2026050515215714700_lvag072-B100","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1530\/EC-17-0321","article-title":"Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center","volume":"7","author":"Falhammar","year":"2018","journal-title":"Endocr Connect"},{"issue":"1","key":"2026050515215714700_lvag072-B101","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/iju.IJU_190_18","article-title":"Changes in blood pressure, blood sugar, and quality of life in patients undergoing pheochromocytoma surgery: a prospective cohort study","volume":"35","author":"Prakash","year":"2019","journal-title":"Indian J Urol"},{"issue":"10","key":"2026050515215714700_lvag072-B102","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1037\/hea0000993","article-title":"Pheochromocytoma and paraganglioma genetic testing: psychological impact","volume":"39","author":"Martins","year":"2020","journal-title":"Health Psychol"},{"issue":"3","key":"2026050515215714700_lvag072-B103","doi-asserted-by":"publisher","first-page":"e24335","DOI":"10.1097\/MD.0000000000024335","article-title":"Determinants of anxiety and depression among pheochromocytoma patients: a case-control study","volume":"100","author":"Jia","year":"2021","journal-title":"Medicine (Baltimore)."},{"issue":"1","key":"2026050515215714700_lvag072-B104","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12672-021-00404-x","article-title":"Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion","volume":"12","author":"Li","year":"2021","journal-title":"Discov Oncol"},{"key":"2026050515215714700_lvag072-B105","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12262-024-04212-9","article-title":"Abdominopelvic paragangliomas: a cohort review of 15-year experience","volume":"87","author":"Agarwal","year":"2024","journal-title":"Indian J Surg."},{"issue":"10431","key":"2026050515215714700_lvag072-B106","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0140-6736(23)02554-0","article-title":"Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial","volume":"403","author":"Baudin","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"2026050515215714700_lvag072-B107","doi-asserted-by":"publisher","first-page":"e230349","DOI":"10.1530\/ERC-23-0349","article-title":"Patient-reported burden associated with pheochromocytoma\/paraganglioma diagnosis","volume":"31","author":"Wolf","year":"2024","journal-title":"Endocr Relat Cancer"},{"issue":"23","key":"2026050515215714700_lvag072-B108","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"2026050515215714700_lvag072-B109","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12672-014-0182-1","article-title":"The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent\/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial","volume":"5","author":"Lerario","year":"2014","journal-title":"Horm Cancer"},{"issue":"5","key":"2026050515215714700_lvag072-B110","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1210\/clinem\/dgz318","article-title":"Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib","volume":"105","author":"Kroiss","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026050515215714700_lvag072-B111","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/EC-20-0196","article-title":"Characteristics of adrenocortical carcinoma in South Korea: a registry-based nationwide survey","volume":"9","author":"Lim","year":"2020","journal-title":"Endocr Connect"},{"issue":"5","key":"2026050515215714700_lvag072-B112","doi-asserted-by":"publisher","first-page":"bvaa040","DOI":"10.1210\/jendso\/bvaa040","article-title":"Patient and partner perspectives on health-related quality of life in adrenocortical carcinoma","volume":"4","author":"Steenaard","year":"2020","journal-title":"J Endocr Soc"},{"issue":"6","key":"2026050515215714700_lvag072-B113","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3390\/cancers14061366","article-title":"Health-related quality of life in adrenocortical carcinoma: development of the disease-specific questionnaire ACC-QOL and results from the PROFILES registry","volume":"14","author":"Steenaard","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2026050515215714700_lvag072-B114","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S2213-8587(23)00193-6","article-title":"Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study","volume":"11","author":"Terzolo","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026050515215714700_lvag072-B115","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/07435800.2024.2402311","article-title":"Adverse events of adjuvant mitotane treatment for adrenocortical carcinoma","volume":"50","author":"Vodanovi\u0107","year":"2025","journal-title":"Endocr Res"},{"issue":"3","key":"2026050515215714700_lvag072-B116","doi-asserted-by":"publisher","first-page":"bvaf226","DOI":"10.1210\/jendso\/bvaf226","article-title":"Changes in body image and pain in patients with Cushing syndrome: a predictor for depression and vice versa","volume":"10","author":"Bednarski","year":"2026","journal-title":"J Endocr Soc"},{"key":"2026050515215714700_lvag072-B117","doi-asserted-by":"publisher","first-page":"116922","DOI":"10.1016\/j.amjsurg.2026.116922","article-title":"The effect of adrenalectomy on the patients with mild autonomous cortisol secretion","volume":"256","author":"Kostek","year":"2026","journal-title":"Am J Surg"},{"issue":"3","key":"2026050515215714700_lvag072-B118","doi-asserted-by":"publisher","first-page":"e917","DOI":"10.1210\/clinem\/dgaf465","article-title":"A global approach to the long-term follow-up of 17 families with bilateral macronodular adrenal disease","volume":"111","author":"Charchar","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"44","key":"2026050515215714700_lvag072-B119","doi-asserted-by":"publisher","first-page":"e45633","DOI":"10.1097\/MD.0000000000045633","article-title":"Effects of psycho-cardiology care on psychological and clinical outcomes among primary aldosteronism patients undergoing adrenal vein sampling: a randomized controlled study","volume":"104","author":"Wan","year":"2025","journal-title":"Medicine (Baltimore)."},{"key":"2026050515215714700_lvag072-B120","doi-asserted-by":"publisher","DOI":"10.1111\/cen.70106","article-title":"Improvement of health-related quality of life and mental health after unilateral adrenalectomy for primary aldosteronism","author":"Fuld","year":"2026","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2026050515215714700_lvag072-B121","doi-asserted-by":"publisher","first-page":"e240266","DOI":"10.1530\/ERC-24-0266","article-title":"A study on the efficacy and safety of anlotinib in patients with metastatic pheochromocytoma and paraganglioma","volume":"32","author":"Cui","year":"2025","journal-title":"Endocr Relat Cancer"},{"issue":"20","key":"2026050515215714700_lvag072-B122","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1056\/nejmoa2504964","article-title":"Belzutifan for advanced pheochromocytoma or paraganglioma","volume":"393","author":"Jimenez","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"2026050515215714700_lvag072-B123","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/ejendo\/lvag003","article-title":"Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection","volume":"194","author":"Fischer","year":"2026","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026050515215714700_lvag072-B124","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/ejendo\/lvaf259","article-title":"Psychosocial burden in adrenocortical carcinoma patients","volume":"194","author":"Kimpel","year":"2026","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026050515215714700_lvag072-B125","doi-asserted-by":"publisher","first-page":"e901","DOI":"10.1210\/clinem\/dgad453","article-title":"Long-term consequences of Cushing syndrome: a systematic literature review","volume":"109","author":"Puglisi","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026050515215714700_lvag072-B126","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1002\/edm2.464","article-title":"Holistic burden of illness in patients with endogenous Cushing's syndrome: a systematic literature review","volume":"7","author":"Page-Wilson","year":"2024","journal-title":"Endocrinol Diabetes Metab"},{"issue":"1","key":"2026050515215714700_lvag072-B127","doi-asserted-by":"publisher","first-page":"e13466","DOI":"10.1111\/jne.13466","article-title":"Cognitive decline in Cushing's syndrome: a systematic review","volume":"37","author":"Katragadda","year":"2025","journal-title":"J Neuroendocrinol"},{"issue":"5","key":"2026050515215714700_lvag072-B128","first-page":"285","article-title":"Are generic and disease-specific health related quality of life correlated? The case of chronic lung disease due to sulfur mustard","volume":"14","author":"Assari","year":"2009","journal-title":"J Res Med Sci"},{"issue":"1","key":"2026050515215714700_lvag072-B129","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12874-021-01279-w","article-title":"Neutral theory: applicability and neutrality of using generic health-related quality of life tools in diseases or conditions where specific tools are available","volume":"21","author":"Jandhyala","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"2026050515215714700_lvag072-B130","doi-asserted-by":"publisher","first-page":"1497055","DOI":"10.3389\/frhs.2025.1497055","article-title":"Standardizing patient-reported outcomes across diseases: development of a novel generic patient-reported outcome set","volume":"5","author":"Long","year":"2025","journal-title":"Front Health Serv"},{"issue":"1","key":"2026050515215714700_lvag072-B131","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0895-4356(02)00537-1","article-title":"Comparative responsiveness of generic and specific quality-of-life instruments","volume":"56","author":"Wiebe","year":"2003","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2026050515215714700_lvag072-B132","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2265.2011.04280.x","article-title":"The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part II: normative data from 1784 healthy people","volume":"76","author":"Milian","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026050515215714700_lvag072-B133","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1365-2265.2011.04191.x","article-title":"The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part I: construction and psychometric properties","volume":"76","author":"Milian","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026050515215714700_lvag072-B134","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/ejendo\/lvag052","article-title":"Quality of life questionnaire development and validation for adrenocortical carcinoma patients","volume":"194","author":"Lagana","year":"2026","journal-title":"Eur J Endocrinol"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag072\/68120057\/lvag072.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/5\/S41\/68120057\/lvag072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/5\/S41\/68120057\/lvag072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:22:06Z","timestamp":1778008926000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/194\/5\/S41\/8659725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":134,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag072","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,21]]}}}